Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies

Neuromuscular Disorders

Volumn 18, Issue 6, 2008, Pages 475-482

  Strach, Katharina ^a   Sommer, Torsten ^a   Grohé, Christian ^a   Meyer, Carsten ^a   Fischer, Dirk ^a,b   Walter, Maggie C ^c   Vorgerd, Matthias ^d   Reilich, Peter ^c   Bär, Harald ^e   Reimann, Jens ^a   Reuner, Ulrike ^f   Germing, Alfried ^d   Goebel, Hans Hilmar ^g   Lochmüller, Hanns ^c   Wintersperger, Bernd ^h   Schröder, Rolf ⁱ  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Muskelzentrum/ALS Clinic   (Switzerland)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cardiac magnetic resonance imaging; Cardiomyopathy; Congenital myopathy; Desminopathy; MR delayed enhancement imaging

Indexed keywords

DESMIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; DESMINOPATHY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; MALE; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DESMIN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45449100121     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.03.012     Document Type: Article

References (46)

1. Goldfarb L.G., Park K.Y., Cervenakova L., et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19 (1998) 402-403
2. Dalakas M.C., Park K.Y., Semino-Mora C., Lee H.S., Sivakumar K., and Goldfarb L.G. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342 (2000) 770-780
3. Selcen D., Ohno K., and Engel A.G. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 127 (2004) 439-451
4. Goldfarb L.G., Vicart P., Goebel H.H., and Dalakas M.C. Desmin myopathy. Brain 127 (2004) 723-734
5. Dagvadorj A., Goudeau B., Hilton-Jones D., et al. Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin c-terminal alpha-helical segment. Muscle Nerve 27 (2003) 669-675
6. Arbustini E., Pasotti M., Pilotto A., et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 8 (2006) 477-483
7. Dagvadorj A., Olive M., Urtizberea J.A., et al. A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol 251 (2004) 143-149
8. Hager S., Mahrholdt H., Goldfarb L.G., Goebel H.H., and Sechtem U. Images in cardiovascular medicine. Giant right atrium in the setting of desmin-related restrictive cardiomyopathy. Circulation 113 (2006) e53-e55
9. Luethje L.G., Boennemann C., Goldfarb L., Goebel H.H., and Halle M. Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27 (2004) 559-560
10. Park K.Y., Dalakas M.C., Goebel H.H., et al. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 37 (2000) 851-857
11. Ahya SN, Paranjothi SP. The Washington Manual of Medical Therapeutics, Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins; 2001.
12. Schiller N.B. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 84 (1991) I280-I287
13. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18 (2002) 539-542
14. Armstrong W.F., Pellikka P.A., Ryan T., Crouse L., and Zoghbi W.A. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 11 (1998) 97-104
15. Bär H., Fischer D., Goudeau B., et al. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet 14 (2005) 1251-1260
16. van der Geest R.J., and Reiber J.H. Quantification in cardiac MRI. J Magn Reson Imaging 10 (1999) 602-608
17. Benjamin E.J., Levy D., Anderson K.M., et al. Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol 70 (1992) 508-515
18. Katz J., Milliken M.C., Stray-Gundersen J., et al. Estimation of human myocardial mass with MR imaging. Radiology 169 (1988) 495-498
19. Holman E.R., Buller V.G., de Roos A., et al. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation 95 (1997) 924-931
20. Bogaert J., Goldstein M., Tannouri F., Golzarian J., and Dymarkowski S. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 180 (2003) 981-985
21. Grebe O., Kestler H.A., Merkle N., et al. Assessment of left ventricular function with steady-state-free-precession magnetic resonance imaging. Reference values and a comparison to left ventriculography. Z Kardiol 93 (2004) 686-695
22. Bottini P.B., Carr A.A., Prisant L.M., Flickinger F.W., Allison J.D., and Gottdiener J.S. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 8 (1995) 221-228
23. Bellenger N.G., Burgess M.I., Ray S.G., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J 21 (2000) 1387-1396
24. Bellenger N.G., Davies L.C., Francis J.M., Coats A.J., and Pennell D.J. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2 (2000) 271-278
25. Myerson S.G., Montgomery H.E., World M.J., and Pennell D.J. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 40 (2002) 673-678
26. Park J.H., Kim Y.M., Chung J.W., Park Y.B., Han J.K., and Han M.C. MR imaging of hypertrophic cardiomyopathy. Radiology 185 (1992) 441-446
27. Sardanelli F., Molinari G., Petillo A., et al. MRI in hypertrophic cardiomyopathy: a morphofunctional study. J Comput Assist Tomogr 17 (1993) 862-872
28. Sharma S., Maron B.J., Whyte G., Firoozi S., Elliott P.M., and McKenna W.J. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 1431-1436
29. Smith G.C., Kinali M., Prasad S.K., et al. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8 (2006) 723-730
30. Silva M.C., Meira Z.M., Gurgel Giannetti J., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49 (2007) 1874-1879
31. Ashford Jr. M.W., Liu W., Lin S.J., et al. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 112 (2005) 2462-2467
32. Maron B.J., Pelliccia A., and Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91 (1995) 1596-1601
33. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
34. Ingkanisorn W.P., Rhoads K.L., Aletras A.H., Kellman P., and Arai A.E. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 43 (2004) 2253-2259
35. Pieroni M., Chimenti C., Ricci R., Sale P., Russo M.A., and Frustaci A. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107 (2003) 1978-1984
36. Varghese A., and Pennell D.J. Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 90 (2004) e59
37. Petrie C.J., Mark P.B., and Dargie H.J. Cardiomyopathy in Becker muscular dystrophy - does regional fibrosis mimic infarction?. J Cardiovasc Magn Reson 7 (2005) 823-825
38. Maeda M., Nakao S., Miyazato H., et al. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy. Am Heart J 129 (1995) 702-707
39. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
40. Kim D.H., Choi S.I., Chang H.J., Choi D.J., Lim C., and Park J.H. Delayed hyperenhancement by contrast-enhanced magnetic resonance imaging: clinical application for various cardiac diseases. J Comput Assist Tomogr 30 (2006) 226-232
41. Yamamoto S., Matsushima H., Suzuki A., Sotobata I., Indo T., and Matsuoka Y. A comparative study of thallium-201 single-photon emission computed tomography and electrocardiography in Duchenne and other types of muscular dystrophy. Am J Cardiol 61 (1988) 836-843
42. Vrabie A., Goldfarb L.G., Shatunov A., et al. The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation. Acta Neuropathol (Berl) 109 (2005) 411-417
43. Bär H., Mücke N., Kostareva A., Sjöberg G., Aebi U., and Herrmann H. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci USA 102 (2005) 15099-15104
44. Bär H., Kostareva A., Sjöberg G., Sejersen T., Katus H.A., and Herrmann H. Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 312 (2006) 1554-1565
45. Bär H., Mücke N., Ringler P., et al. Impact of disease mutations on the desmin filament assembly process. J Mol Biol 360 (2006) 1031-1042
46. Goudeau B., Rodrigues-Lima F., Fischer D., et al. Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. Hum Mutat 27 (2006) 906-913